Engineering vs Biotech: The Patent Gender Gap by Field

The headline statistic is 12.8% women inventors. The actual numbers by field range from 6% to nearly 18%.

That spread matters because the fields that produce the most patents also have the fewest women in them. Software and mechanical engineering dominate US filing volume. Biotech and chemistry, where women are closest to parity, produce relatively fewer patents. The aggregate gap is not just a head count problem. It is a field-composition problem.

This page breaks the gap down by USPC technology area, explains why biotech leads, and walks through what the field-level data implies about where interventions actually move the needle.

This article presents published research data for educational purposes. It is not legal, policy, or investment advice. Patent gender statistics depend on name-based inference and methodology choices: see How we measure.

The numbers by field

USPTO field-level women inventor rates, most recent data available. Some numbers come from the USPTO's 2020 Progress and Potential report (covering data through 2019); others from the National Science Board's 2024 indicators report (covering 2022). Methodologies differ slightly, but the rank order is consistent.

Sources: USPTO Progress and Potential: 2020 Update; National Science Board, Science & Engineering Indicators 2024.

The volume mismatch nobody talks about

The aggregate gender gap is not just a question of rates by field. It is also a question of which fields produce the most patents.

US patent volume is dominated by software, electrical engineering, and mechanical engineering: the three fields with the lowest women inventor rates. Biotech and pharmaceuticals, where women are nearly at parity, produce a much smaller share of total US patent volume. The result is a mathematical compounding: even modest growth in women's biotech patenting rates barely moves the headline number, because biotech's slice of the total pie is small.

The National Science Board's 2024 indicators report tracked this composition effect across two decades. Women's overall share of US patents (any inventor) grew from 7.2% in 2000 to 10.9% in 2022. The slowness of that growth reflects not a slowing of women's entry into individual fields but the relative growth of low-women-participation fields (especially software and AI) outpacing the relative growth of higher-participation fields.

Why biotech and chemistry lead

The structural drivers behind biotech's gender parity are well documented and largely upstream of the patent system itself.

1. The biomedical pipeline is more gender-balanced

Women earn approximately 48% of US biomedical PhDs and roughly half of biological-sciences bachelor's degrees. Mechanical and electrical engineering doctoral programs remain in the 20-25% range. The pipeline composition almost mechanically predicts the patenting composition.

2. The Koning et al. women's health finding

Koning, Samila, and Ferguson (Science, 2021) analyzed 441,504 US biomedical patents from 1976-2010 and found that all-female inventor teams are 35% more likely than all-male teams to focus on women's health needs. Majority-female teams are 18% more likely. The effect held across decades and research areas.

The implication is structural: women inventors are not just under-represented in biomedical patenting; they are systematically working on problems that male-dominated teams would not otherwise prioritize. The biotech parity number reflects both pipeline composition and a content-of-invention shift that closes parity by widening the addressable research space.

3. University filing patterns

Universities file the majority of biotech patents in the US and have notably more gender-balanced researcher pools than industry. The Stanford Office of Technology Licensing's 50-year analysis (Tseng et al., Patterns, 2022) tracked women's share of inventors rising from roughly 7% in the mid-1990s to roughly 20% by 2020. Stanford's biotech-tilted faculty composition is part of why university-filed biotech leads the field.

Why mechanical engineering and software lag

The bottom of the field-level table is not random either. Hunt, Garant, Herman, and Munroe (NBER Working Paper 17888, 2013) found that 78% of the patenting gender gap is explained by which scientific or engineering field women are in, not by whether they have a STEM degree at all. The under-representation of women in electrical engineering and mechanical engineering, combined with under-representation in development-and-design roles within those fields, accounts for most of the headline gap.

Software and ICT show a similar pattern. The pipeline (women earn ~21% of computer science bachelor's degrees in the US) sets a ceiling that the patent system cannot exceed. Within software, the patenting rate then drops further because patentable software inventions tend to come disproportionately from senior individual contributors and architects, roles where women's representation thins further with seniority.

Hunt et al. estimated that closing the patent gender gap by raising women's representation in under-represented fields would lift US GDP per capita by 2.7%. The number is dated (2013) but the underlying logic is unchanged: under-represented fields are economically valuable, and the cost of the field-composition gap shows up in the macroeconomy, not just in the patent system.

What field-level interventions actually move the needle

Field-level data points at field-level interventions. The Washington University Women in Innovation & Technology (WIT) program is the canonical example: rather than a general "encourage women to patent" campaign, it focused on biomedical research faculty, where the pipeline was already balanced but disclosure rates lagged. The result was a 129% increase in patents filed on behalf of women faculty between 2011-13 and 2013-16.

Two implications follow:

• The highest-leverage interventions target fields where the pipeline is balanced but the disclosure or filing rate is not. Biotech fits this perfectly. Mechanical engineering does not.
• Pipeline interventions matter most in low-participation fields. Software and mechanical engineering need decades of upstream change to materially shift the patent numbers. There is no patent-system-only fix.

See Closing strategies that work for the full picture of evidence-based interventions.

Field composition shapes what gets invented

The Koning et al. finding generalizes. Different inventor populations focus on different problems. The 6,500 "missing" female-focused biomedical inventions estimated for the 1976-2010 period (had patent parity existed) is the most-cited number, but it is a floor not a ceiling: the analogous number for AI, materials science, or consumer hardware has not been measured but is plausibly larger in absolute terms.

Field-level gender composition shapes the addressable problem space the US patent system can produce solutions for. When mechanical engineering is 94% male-inventor, the inventions made are disproportionately the ones that male engineers identify as worth making. That is not a moral claim about the inventions themselves; it is a structural claim about which problems get attention. Closing the field-level gaps changes the composition of what gets built.

Sources

More from the patent gender gap series